Published by Josh White on 12th August 2025
(Sharecast News) - Ixico has secured two new clinical trial contracts in neurological disorders with a combined value of about £1.3m, it announced on Friday, extending its presence in both Alzheimer's disease and rare central nervous system conditions.
URL: http://www.digitallook.com/dl/news/story/35281245/...